TCR2 Therapeutics Inc. buy BiotechBee
Start price
04.02.23
/
50%
€1.31
Target price
04.02.24
€3.00
Performance (%)
34.48%
End price
05.05.23
€1.76
Summary
This prediction ended on 05.05.23 with a price of €1.76. With a performance of 34.48% the BUY prediction by BiotechBee was a big success. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| TCR2 Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 1.014% | 2.699% | 4.363% | 51.689% |
| iShares Nasdaq 100 | -6.470% | -8.771% | 18.004% | 67.992% |
| iShares Nikkei 225® | -6.517% | -12.580% | 40.915% | 57.109% |
| iShares S&P 500 | -2.721% | -1.752% | 16.966% | 58.872% |
According to BiotechBee what are the pros and cons of TCR2 Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year